- Record first quarter total revenue of $21.5 million, up 11% year-over-year
- Positive cash flows, with Adjusted EBITDA(1) of $1.5 million, up 15% year-over-year
- On April 1, Stephen Lemieux assumed the role of Chief Executive Officer
- Investor webinar scheduled for Thursday, May 14, 2026 at 10:00 AM ET / 7:00 AM PT
TORONTO, ONTARIO, May 14, 2026 – NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”) operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic pain, musculoskeletal/back pain, sports medicine and other pain medical services, today announced its financial and operating results for the three months ended March 31, 2026 and information regarding the Company’s investor webinar on Thursday, May 14, 2026. All figures are in Canadian dollars, unless otherwise noted.
“We continue to see positive financial results with increased patient visits and record first quarter total revenue and year-over-year growth in Adjusted EBITDA,” said Stephen Lemieux, NeuPath’s Chief Executive Officer. “We remain committed to enhancing profitability and shareholder value while advancing our strategic growth objectives. Integral to our growth is the onboarding of new physicians to treat more patients and we have been successful in this area during the quarter. We continue to look at opportunities to increase our service offerings and expand our footprint across Canada, including a new location in Guelph, Ontario, that is expected to be open to patients in late Q3.”
Financial and Operational Highlights
- Total revenue was $21.5 million for the three months ended March 31, 2026 compared to $19.3 million for the three months ended March 31, 2025, up 11% compared to the first quarter of 2025, delivering record first quarter total revenues;
- Adjusted EBITDA was $1.5 million for the three months ended March 31, 2026 compared to $1.3 million for the three months March 31, 2025, up 15% year-over-year; and
- As at March 31, 2026, the Company had $3.5 million in cash and cash equivalents and interest-bearing long-term debt of $6.0 million.
(1) IFRS Accounting Standards (“IFRS”) and Other Financial Measures defined by the Company below.
View entire press release – PDF